GA-68 PSMA

About Ga-68 PSMA PET CT

Ga-68 PSMA PET CT is a specialized nuclear medicine imaging examination that uses a Gallium-68 labelled PSMA radiotracer to detect areas showing prostate-specific membrane antigen (PSMA) expression. It combines functional PET imaging with anatomical CT imaging to provide information about the location and distribution of PSMA-avid lesions.

Ga-68 PSMA PET CT is primarily used in the evaluation of prostate cancer when PSMA-targeted imaging is clinically indicated.

What Does Ga-68 PSMA PET CT Evaluate?

This examination evaluates the distribution and uptake of the Ga-68 PSMA radiotracer in the body. It can help identify areas of increased PSMA expression that may correspond to prostate cancer or related disease sites.

The findings may provide information about the prostate region, lymph nodes, bones and other areas of the body and can be correlated with clinical findings, PSA levels, pathology and other imaging studies.

Why Is Ga-68 PSMA PET CT Performed?

Doctors may recommend Ga-68 PSMA PET CT for selected patients with prostate cancer when PSMA-targeted imaging is clinically required.

It may be used for initial assessment in selected patients, evaluation of suspected recurrent or persistent disease, assessment of disease spread and treatment planning or follow-up when clinically appropriate. The exact indication is determined by the treating specialist.

How Is Ga-68 PSMA PET CT Performed?

The prescribed Ga-68 PSMA radiotracer is administered under the supervision of the nuclear medicine team. After an appropriate uptake period, PET and CT images are acquired using the PET CT scanner.

The patient needs to remain as still as possible during image acquisition. The nuclear medicine team provides instructions regarding tracer administration, positioning and scan timing.

The duration of the examination may vary depending on the prescribed imaging protocol and clinical requirements.

Preparation for Ga-68 PSMA PET CT

Preparation requirements may vary according to the clinical indication and imaging protocol. Patients should follow the specific instructions provided by the nuclear medicine team before the examination.

Patients should inform the nuclear medicine team about current medications, previous treatments, pregnancy or possible pregnancy, breastfeeding and other relevant medical conditions before the scan.

Patients should not stop or change prescribed medicines unless specifically instructed by their treating doctor or nuclear medicine team.

Benefits of Ga-68 PSMA PET CT

Ga-68 PSMA PET CT provides functional information about PSMA expression together with anatomical information from CT. This can help physicians identify and localize PSMA-avid lesions throughout the body.

The examination can provide additional information for disease assessment, staging, evaluation of suspected recurrence and treatment planning in appropriate patients with prostate cancer.

Understanding the Ga-68 PSMA PET CT Report

The report may describe areas of increased or abnormal PSMA uptake along with relevant anatomical findings on CT. The significance of tracer uptake depends on its location, intensity, imaging characteristics and clinical context.

PET CT findings should be interpreted by a qualified nuclear medicine physician together with PSA levels, pathology, symptoms, treatment history and other relevant investigations.

Ga-68 PSMA PET CT in Hyderabad

Focus Diagnostics provides advanced PET CT and nuclear medicine imaging services in Hyderabad for appropriate clinical indications. Patients can consult their referring physician or nuclear medicine team regarding preparation, appointment requirements and report interpretation.